--- title: Newsroom | Healthcare (4) description: Healthcare | (4) --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [AI (2)](https://news.lifesciencenewswire.com/newsroom/tag/ai) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (35)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (23)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (16)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (252)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (38)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (117)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (288)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (38)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology) - [Drug Discovery & Development (153)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (136)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (26)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (87)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Medical Devices & Technology](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) #### [Revolutionary danish cancer app set for nationwide launch: A milestone in digital healthcare](https://news.lifesciencenewswire.com/newsroom/revolutionary-danish-cancer-app-set-for-nationwide-launch-a-milestone-in-digital-healthcare) December 6, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/revolutionary-danish-cancer-app-set-for-nationwide-launch-a-milestone-in-digital-healthcare) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/revolutionary-danish-cancer-app-set-for-nationwide-launch-a-milestone-in-digital-healthcare#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Dec 6, 2023, 12:55:00 PM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) #### [PrecisionLife announces new appointments to launch diagnostics and healthcare strategy](https://news.lifesciencenewswire.com/newsroom/precisionlife-announces-new-appointments-to-launch-diagnostics-and-healthcare-strategy) November 22, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/precisionlife-announces-new-appointments-to-launch-diagnostics-and-healthcare-strategy) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/precisionlife-announces-new-appointments-to-launch-diagnostics-and-healthcare-strategy#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Nov 22, 2023, 12:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Medical Devices & Technology](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) #### [ICS/ICB leaders Penny Dash and Paul Miller announced as speakers for the NHS Transformation Symposium](https://news.lifesciencenewswire.com/newsroom/ics/icb-leaders-penny-dash-and-paul-miller-announced-as-speakers-for-the-nhs-transformation-symposium) August 9, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ics/icb-leaders-penny-dash-and-paul-miller-announced-as-speakers-for-the-nhs-transformation-symposium) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/ics/icb-leaders-penny-dash-and-paul-miller-announced-as-speakers-for-the-nhs-transformation-symposium#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Aug 9, 2023, 12:30:00 PM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Tillotts Pharma and TVM Capital Life Science announce formation of Mage Biologics to develop innovative oral antibody therapy for ulcerative colitis](https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-and-tvm-capital-life-science-announce-formation-of-mage-biologics-to-develop-innovative-oral-antibody-therapy-for-ulcerative-colitis) July 20, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-and-tvm-capital-life-science-announce-formation-of-mage-biologics-to-develop-innovative-oral-antibody-therapy-for-ulcerative-colitis) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/tillotts-pharma-and-tvm-capital-life-science-announce-formation-of-mage-biologics-to-develop-innovative-oral-antibody-therapy-for-ulcerative-colitis#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jul 20, 2023, 1:18:59 PM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) #### [PrecisionLife identifies first detailed genetic risk factors for long COVID and common mechanisms with ME/CFS and other complex diseases](https://news.lifesciencenewswire.com/newsroom/precisionlife-identifies-first-detailed-genetic-risk-factors-for-long-covid-and-common-mechanisms-with-me/cfs-and-other-complex-diseases) July 18, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/precisionlife-identifies-first-detailed-genetic-risk-factors-for-long-covid-and-common-mechanisms-with-me/cfs-and-other-complex-diseases) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/precisionlife-identifies-first-detailed-genetic-risk-factors-for-long-covid-and-common-mechanisms-with-me/cfs-and-other-complex-diseases#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jul 18, 2023, 12:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [PrecisionLife licenses University of Oxford data to discover personalised treatments for endometriosis patients](https://news.lifesciencenewswire.com/newsroom/precisionlife-licenses-university-of-oxford-data-to-discover-personalised-treatments-for-endometriosis-patients) June 29, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/precisionlife-licenses-university-of-oxford-data-to-discover-personalised-treatments-for-endometriosis-patients) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/precisionlife-licenses-university-of-oxford-data-to-discover-personalised-treatments-for-endometriosis-patients#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 29, 2023, 9:00:00 AM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [Meissa Vaccines enters into CGMP manufacturing agreement for pediatric RSV vaccine candidate for phase 2 clinical trials](https://news.lifesciencenewswire.com/newsroom/meissa-vaccines-enters-into-cgmp-manufacturing-agreement-for-pediatric-rsv-vaccine-candidate-for-phase-2-clinical-trials) June 28, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/meissa-vaccines-enters-into-cgmp-manufacturing-agreement-for-pediatric-rsv-vaccine-candidate-for-phase-2-clinical-trials) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/meissa-vaccines-enters-into-cgmp-manufacturing-agreement-for-pediatric-rsv-vaccine-candidate-for-phase-2-clinical-trials#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 28, 2023, 8:00:00 AM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [AntlerA Norrin/Wnt-agonist ANT antibody enters clinical trials through a strategic partnership with EyeBio](https://news.lifesciencenewswire.com/newsroom/antlera-norrin/wnt-agonist-ant-antibody-enters-clinical-trials-through-a-strategic-partnership-with-eyebio) June 15, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/antlera-norrin/wnt-agonist-ant-antibody-enters-clinical-trials-through-a-strategic-partnership-with-eyebio) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/antlera-norrin/wnt-agonist-ant-antibody-enters-clinical-trials-through-a-strategic-partnership-with-eyebio#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 15, 2023, 12:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [SMi discloses £6 million seed funding round, bolsters team with new C-suite hire](https://news.lifesciencenewswire.com/newsroom/smi-discloses-6-million-seed-funding-round-bolsters-team-with-new-c-suite-hire) June 14, 2023 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/smi-discloses-6-million-seed-funding-round-bolsters-team-with-new-c-suite-hire) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/smi-discloses-6-million-seed-funding-round-bolsters-team-with-new-c-suite-hire#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 14, 2023, 1:30:00 PM - [Tweet](https://twitter.com/share) [Previous](https://news.lifesciencenewswire.com/newsroom/tag/healthcare/page/3) [All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/healthcare/page/5) ##### Browse more news ## Recent releases #### [Ceryx Medical manufactures first implantable heart failure device at King’s College London’s MAISI f...](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility) October 22, 2026 A first for both organisations: the first implantable device built by the UK’s national active implant manufacturing facility is Ceryx’s bioelectronic... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility) #### [Scope’s CRISPR Molecular Diagnostics CE Marked for Antifungal Resistance](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) October 6, 2026 Developed with AmplexDiagnostics, eazySNP brings scopeDx® into human diagnostics Scope Biosciences B.V., a Wageningen University spinoff life sciences... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) #### [CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) October 5, 2026 Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise CellCar... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)